US 10233250
Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10233250 (Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39541, A61K39/3955